An independent guide to cash-pay care. Every price is dated and sourced.

How we check
Wellchosen Health

Medical weight loss in Palm Beach

In Palm Beach County, where 26.1% of residents are 65 or older [1], the most useful weight-loss development of 2026 is federal: Medicare's GLP-1 Bridge lets qualifying Part D members get Wegovy, Foundayo or the Zepbound KwikPen for $50 a month until the end of 2027 [2][3]. Younger residents mostly pay cash, from $149 a month [4].

Updated Oct 17, 2026By the Wellchosen Health editorial team

Medical review: pending. A licensed clinician has not yet reviewed this page.

Medical weight loss is supervised obesity care from a licensed prescriber, typically pairing an approved medicine with diet, activity and follow-up.

Palm Beach County residents 65+
26.1 percent [1]
Countywide adult obesity
26.6 percent, 2023 model [5]
Countywide adult diabetes
13.7 percent [5]
Obesity inside West Palm Beach city
29.1 percent [6]
Florida Medicaid, obesity GLP-1s
Not among covering states [7]

Compare GLP-1 prices

Older, and more diabetic than the obesity rate suggests

Palm Beach County counts 1,575,726 people, and better than one in four is 65 or older [1]. CDC's 2023 model puts county obesity at a fairly low 26.6%, but diagnosed diabetes at 13.7% [5]. Inside West Palm Beach itself the obesity estimate climbs to 29.1%, with diabetes again at 13.7% [6]. A diabetes rate that high matters, since it changes which brand a prescriber reaches for and which insurance rules apply.

Whatever appears under Sponsored was bought by a local practice. That is the whole of it: no review by us, no endorsement.

Medicare's Bridge, explained for Palm Beach retirees

  • What it pays for: Foundayo in any form, Wegovy shots or tablets, and the Zepbound KwikPen. Ozempic and Zepbound vials or single-dose pens are left out [2].
  • Your share: $50 for each month's supply [3].
  • Who qualifies: a Part D member 18 or older with a BMI of 35+, or 30+ with heart failure with preserved ejection fraction, uncontrolled hypertension or stage 3a+ kidney disease, or 27+ with prediabetes, a past heart attack or stroke, or symptomatic peripheral artery disease [3].
  • Paperwork: Humana handles the prior authorization for everyone, decides within 72 hours, and an approval holds through December 31, 2027 unless you change drugs [2].

Zepbound prescribed for sleep apnea stays in your normal Part D plan instead [2]. Our Medicare GLP-1 page has more.

Tirzepatide and semaglutide for cash buyers

Monthly and full-year drug cost at maintenance doses (prices Oct 17, 2026; yearly figures are our arithmetic)
MedicineMaintenance priceFills per yearYear of drugRef
Zepbound 7.5 to 15 mg (tirzepatide)$449 per 28 days13$5,837[8]
Wegovy pen (semaglutide)$349 per box12$4,188[4]
Wegovy 25 mg tablets (semaglutide)$299 a month12$3,588[4]
Starting doses cost less. Clinic visits and labs are on top. See the GLP-1 cost page for each dose.

Tirzepatide had the larger average effect when the two were tested head to head: 20.2% weight loss at 72 weeks against 13.7% for semaglutide [9]. Price lists: all GLP-1s, tirzepatide, semaglutide.

Jupiter Medical Center and other local options

Jupiter Medical Center has a weight loss services page on its site [10]. We could not confirm what that program includes or what it charges, so ask directly. Independent clinics and med spas across the county also sell GLP-1 programs; ask each whether it dispenses a brand product or a compounded one, because FDA says compounded semaglutide and tirzepatide are not FDA-approved [11].

Florida Medicaid

Florida does not appear among the 13 state Medicaid programs KFF found paying for obesity GLP-1s in January 2026 [7].

Signs that need attention

Intense stomach pain that does not fade can be pancreatitis, which every GLP-1 label lists; stop and call. Rash, swelling or trouble breathing after a dose also needs prompt care. With 13.7% of county adults diabetic, note that insulin and sulfonylureas make low blood sugar more likely on these drugs. Thyroid C-cell tumors in rodents are the basis of the boxed warning [12][13]. In an emergency, dial 911.

Confirm licenses with the Florida Board of Medicine [14]. Nearby: Boca Raton weight loss, Fort Lauderdale, Miami. Also the weight loss hub and how to vet a clinic.

Questions people ask

Can Palm Beach seniors on Medicare get Wegovy or Zepbound for weight?

If they qualify for the Medicare GLP-1 Bridge, yes: Wegovy, Foundayo and the Zepbound KwikPen at $50 a month through December 31, 2027. Ozempic and Zepbound vials are excluded [2][3].

How long does Bridge approval take?

Humana processes the prior authorization centrally and decides within 72 hours, per CMS [2].

What does tirzepatide cost in Palm Beach without insurance?

LillyDirect sold Zepbound for $299 to $449 per 28-day fill on October 17, 2026; at $449, 13 fills make about $5,837 a year [8].

How common is diabetes in Palm Beach County?

CDC PLACES estimates 13.7% of adults in Palm Beach County had diagnosed diabetes in 2023 [5].

Does Jupiter Medical Center offer weight loss care?

It lists weight loss services on its website; we could not confirm the program details or price [10].

Does Florida Medicaid pay for obesity GLP-1s?

Florida was not among the 13 state Medicaid programs KFF counted as covering them in January 2026 [7].

Sources

14 cited
  1. QuickFacts: Palm Beach County, Florida. U.S. Census Bureau, V2025 estimates and ACS 2020 to 2024, accessed 2026-10-17.
  2. Medicare GLP-1 Bridge: information for pharmacies. Centers for Medicare & Medicaid Services, accessed 2026-10-17.
  3. Weight loss drugs coverage. Medicare.gov, accessed 2026-10-17.
  4. Wegovy self-pay offer. Novo Nordisk (NovoCare), accessed 2026-10-17.
  5. PLACES county estimates: Palm Beach County, FL. CDC PLACES (2025 release, BRFSS 2023), 2025 release.
  6. PLACES place estimates: West Palm Beach, FL. CDC PLACES (2025 release, BRFSS 2023), 2025 release.
  7. Medicaid coverage of and spending on GLP-1s. KFF, Jan 16, 2026.
  8. Zepbound self-pay pricing. Eli Lilly and Company (LillyDirect), accessed 2026-10-17.
  9. Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). New England Journal of Medicine (PubMed), May 11, 2025.
  10. Weight loss services. Jupiter Medical Center, accessed 2026-10-17.
  11. FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
  12. Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration, Apr 2026.
  13. Wegovy label. DailyMed, NLM, Jun 2026.
  14. Florida Board of Medicine. Florida Department of Health, accessed 2026-10-17.

This page is general information, not medical advice. Talk with a licensed clinician about your own care.

Compare GLP-1 prices